Pharmaceuticals Insider Trading
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
Activity
About industry performance (blue line)
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.
Recent Transactions
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2015 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 3,000 | $60.02 | $180,060.00 | -51.3% | |
| Aug 14, 2015 | RMTI Rockwell Medical, Inc. | Chioini Robert L | Chairman, President And CEO | Buy | 4,910 | $11.96 | $58,723.60 | +0.3% | |
| Aug 13, 2015 | RMTI Rockwell Medical, Inc. | Pratt Raymond Dennis | VP Of Drug Development | Buy | 5,000 | $11.54 | $57,675.44 | +1.6% | |
| Aug 13, 2015 | RMTI Rockwell Medical, Inc. | Chioini Robert L | Chairman, President And CEO | Buy | 5,090 | $11.51 | $58,597.70 | - | |
| Aug 13, 2015 | RMTI Rockwell Medical, Inc. | Gupta Ajay | Chief Scientific Officer | Buy | 5,000 | $11.62 | $58,112.00 | +0.8% | |
| Aug 13, 2015 | EBS Emergent Biosolutions Inc. | Joulwan George A | Director | Sell | 7,200 | $34.72 | $249,984.00 | -27.0% | |
| Aug 13, 2015 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 4,922 | $36.00 | $177,192.00 | -26.4% | |
| Aug 12, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 22,657 | $39.30 | $890,409.82 | -9.9% | |
| Aug 12, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 22,657 | $39.30 | $890,409.82 | -9.9% | |
| Aug 11, 2015 | AMRN Amarin Corp Plc\uk | Thero John F | President And CEO | Buy | 20,000 | $2.35 | $47,000.00 | +7.0% | |
| Aug 10, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 30,000 | $35.50 | $1,065,000.00 | -1.6% | |
| Aug 7, 2015 | ANIK Anika Therapeutics, Inc. | Moran John C | Director | Sell | 2,000 | $36.18 | $72,360.00 | -11.9% | |
| Aug 6, 2015 | JNJ Johnson & Johnson | Prince Charles | Director | Buy | 2,500 | $99.25 | $248,131.50 | +10.8% | |
| Aug 6, 2015 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 29,766 | $34.50 | $1,026,927.00 | -1.6% | |
| Aug 6, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $38.66 | $695,862.00 | -8.0% | |
| Aug 6, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 18,000 | $38.66 | $695,862.00 | -8.0% | |
| Aug 3, 2015 | EGRX Eagle Pharmaceuticals, Inc. | Tarriff Scott | President And CEO | Sell | 13,000 | $96.19 | $1,250,408.26 | -0.4% | |
| Jul 31, 2015 | MRK Merck & Co., Inc. | Golestani Clark | EVP &Chief Info Officer | Sell | 31,831 | $59.09 | $1,880,804.60 | -18.4% | |
| Jul 31, 2015 | ANIK Anika Therapeutics, Inc. | Land Raymond J | Director | Sell | 1,708 | $37.61 | $64,238.78 | -5.6% | |
| Jul 31, 2015 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 20,807 | $38.39 | $798,685.48 | -8.9% | |
| Jul 31, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 20,807 | $38.39 | $798,685.48 | -8.9% | |
| Jul 28, 2015 | LLY Eli Lilly & Co | Mahony Susan | SVP &Pres., Lilly Oncology | Sell | 25,000 | $84.96 | $2,124,000.00 | -28.5% | |
| Jul 28, 2015 | SUPN Supernus Pharmaceuticals, Inc. | Schwabe Stefan K.F. | Executive Vice President R&D | Sell | 2,350 | $21.20 | $49,826.50 | -58.0% | |
| Jul 27, 2015 | SNY Sanofi | Sanofi | 10% Owner | Buy | 10,639 | $537.48 | $5,718,271.92 | - | |
| Jul 24, 2015 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 18,000 | $37.98 | $683,634.00 | -7.7% |